Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：54

作者：

D'Addario, G. ^{[1
]}

Felip, E. ^{[2
]}

机构：

[1] Kantonsspital, Dept Oncol, St Gallen, Switzerland

[2] Hosp Univ Vail DHebron, Med Oncol Serv, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn081

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：39 / 40

页数：2

共 16 条

[1]

[Anonymous], 1995, BMJ

[2] Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC):: A meta-analysis of individual data from 1764 patients [J].

Aupérin, A ;

Le Péchoux, C ;

Pignon, JP ;

Koning, C ;

Jeremic, B ;

Clamon, G ;

Einhorn, L ;

Ball, D ;

Trovo, MG ;

Groen, HJM ;

Bonner, JA ;

Le Chevalier, T ;

Arriagada, R .

ANNALS OF ONCOLOGY, 2006, 17 (03) :473-483

[3] Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis [J].

Burdett, S ;

Stewart, L .

LUNG CANCER, 2005, 47 (01) :81-83

[4] European trends in preoperative and intraoperative nodal staging: ESTS guidelines [J].

De Leyn, P. ;

Lardinois, D. ;

Van Schil, P. ;

Rami-Porta, R. ;

Passlick, B. ;

Zielinski, M. ;

Waller, D. ;

Lerut, T. ;

Weder, W. .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) :357-361

[5] Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].

Depierre, A ;

Milleron, B ;

Moro-Sibilot, D ;

Chevret, S ;

Quoix, E ;

Lebeau, B ;

Braun, D ;

Breton, JL ;

Lemarié, E ;

Gouva, S ;

Paillot, N ;

Bréchot, JM ;

Janicot, H ;

Lebas, FX ;

Terrioux, P ;

Clavier, J ;

Foucher, P ;

Monchâtre, M ;

Coëtmeur, D ;

Level, MC ;

Leclerc, P ;

Blanchon, F ;

Rodier, JM ;

Thiberville, L ;

Villeneuve, A ;

Westeel, V ;

Chastang, C .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253

[6]

Douillard JY, 2006, LANCET ONCOL, V7, P797

[7] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].

Douillard, Jean-Yves ;

Rosell, Rafael ;

De Lena, Mario ;

Carpagnano, Francesco ;

Ramlau, Rodryg ;

Gonzales-Larriba, Jose Luis ;

Grodzki, Tornasz ;

Pereira, Jose Rodrigues ;

Le Groumellec, Alain ;

Lorusso, Vito ;

Clary, Claude ;

Torres, Antonio J. ;

Dahabreh, Jabrail ;

Souquet, Pierre-Jean ;

Astudillo, Julio ;

Fournel, Pierre ;

Artal-Cortes, Angel ;

Jassem, Jacek ;

Koubkova, Leona ;

His, Patricia ;

Riggi, Marcella ;

Hurteloup, Patrick .

LANCET ONCOLOGY, 2006, 7 (09) :719-727

[8] Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J].

Furuse, K ;

Fukuoka, M ;

Kawahara, M ;

Nishikawa, H ;

Takada, Y ;

Kudoh, S ;

Katagami, N ;

Ariyoshi, Y .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2692-2699

[9] Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].

Hanna, N ;

Shepherd, FA ;

Fossella, FV ;

Pereira, JR ;

De Marinis, F ;

von Pawel, J ;

Gatzemeier, U ;

Tsao, TCY ;

Pless, M ;

Muller, T ;

Lim, HL ;

Desch, C ;

Szondy, K ;

Gervais, R ;

Shaharyar ;

Manegold, C ;

Paul, S ;

Paoletti, P ;

Einhorn, L ;

Bunn, PA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597

[10] Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trial [J].

Kosmidis, P ;

Mylonakis, N ;

Nicolaides, C ;

Kalophonos, C ;

Samantas, E ;

Boukovinas, J ;

Fountzilas, G ;

Skarlos, D ;

Economopoulos, T ;

Tsavdaridis, D ;

Papakostas, P ;

Bacoyiannis, C ;

Dimopoulos, M .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3578-3585

← 1 2 →